Parmax Pharma Ltd

Parmax Pharma Ltd

₹ 29.8 1.71%
25 Apr - close price
About

Incorporated in 1994, Parmax Pharma Ltd manufactures bulk drugs, drugs intermediates, and specialty chemicals[1]

Key Points

Business Overview:[1]
Company used to do manufacturing bulk drugs and specialty chemicals but it discontinued its business activities for a few years. It deals in active pharmaceutical ingredients and Contract Manufacturing Operations. It plans to extend its activity to the formulation of Tablets, Ointments,
Capsules, and Injectables.

  • Market Cap 11.2 Cr.
  • Current Price 29.8
  • High / Low 36.6 / 24.2
  • Stock P/E
  • Book Value 8.50
  • Dividend Yield 0.00 %
  • ROCE 3.94 %
  • ROE -1.69 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 3.51 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.31% over past five years.
  • Promoter holding is low: 30.8%
  • Company has a low return on equity of 4.58% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
7.39 1.73 6.54 2.89 7.09 1.56 2.13 5.35 6.38 1.40 4.07 1.33
6.70 1.62 4.84 2.82 6.40 2.34 2.26 3.03 5.54 2.05 4.84 2.48
Operating Profit 0.69 0.11 1.70 0.07 0.69 -0.78 -0.13 2.32 0.84 -0.65 -0.77 -1.15
OPM % 9.34% 6.36% 25.99% 2.42% 9.73% -50.00% -6.10% 43.36% 13.17% -46.43% -18.92% -86.47%
0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Interest 0.06 0.09 0.10 0.11 0.09 0.09 0.12 0.11 0.05 0.12 0.18 0.16
Depreciation 0.50 0.47 0.48 0.48 0.50 0.46 0.47 0.48 0.47 0.42 0.43 0.45
Profit before tax 0.15 -0.43 1.14 -0.51 0.12 -1.32 -0.71 1.74 0.33 -1.18 -1.37 -1.75
Tax % 300.00% 0.00% 0.00% 0.00% 141.67% 0.00% 0.00% 0.00% 48.48% 0.00% 0.00% 0.00%
-0.30 -0.44 1.14 -0.52 -0.05 -1.32 -0.70 1.74 0.17 -1.18 -1.37 -1.75
EPS in Rs -0.80 -1.18 3.05 -1.39 -0.13 -3.53 -1.87 4.65 0.45 -3.15 -3.66 -4.68
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
0.00 0.00 0.00 0.00 0.00 0.00 11.89 11.99 20.92 26.17 18.24 15.40 13.18
0.00 0.03 0.02 0.02 0.05 0.05 10.81 10.88 19.15 22.74 15.67 13.12 14.91
Operating Profit 0.00 -0.03 -0.02 -0.02 -0.05 -0.05 1.08 1.11 1.77 3.43 2.57 2.28 -1.73
OPM % 9.08% 9.26% 8.46% 13.11% 14.09% 14.81% -13.13%
0.00 0.00 0.06 0.06 0.06 0.06 0.05 0.05 0.10 0.09 0.06 0.04 0.04
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.03 0.13 0.37 0.39 0.40 0.51
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 1.09 1.03 1.01 1.94 1.93 1.88 1.77
Profit before tax 0.00 -0.03 0.04 0.04 0.01 0.01 0.00 0.10 0.73 1.21 0.31 0.04 -3.97
Tax % 0.00% 0.00% 25.00% 200.00% 100.00% 20.00% 41.10% 38.02% 54.84% 375.00%
0.00 -0.03 0.04 0.02 0.00 -0.01 0.00 0.08 0.43 0.75 0.14 -0.10 -4.13
EPS in Rs -0.08 0.10 0.05 0.00 -0.03 0.00 0.21 1.15 2.00 0.37 -0.27 -11.04
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: -10%
TTM: -18%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -1152%
Stock Price CAGR
10 Years: %
5 Years: 11%
3 Years: -15%
1 Year: -4%
Return on Equity
10 Years: 3%
5 Years: 5%
3 Years: 5%
Last Year: -2%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 3.90 3.90 3.90 4.03 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45
Reserves 0.09 0.06 0.09 0.12 0.11 0.10 0.11 0.18 0.61 1.37 1.51 1.40 -1.27
0.87 0.90 0.92 0.79 0.46 1.02 1.96 5.52 5.26 5.89 5.18 5.37 5.49
0.08 0.08 0.09 0.04 0.06 2.14 10.11 9.56 10.75 11.01 6.83 6.39 6.77
Total Liabilities 4.94 4.94 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.44
2.53 2.53 2.53 2.53 2.53 2.72 5.86 4.92 9.64 10.84 10.44 9.50 9.11
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.33 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.20 0.20 0.00 0.00 0.00
2.41 2.41 2.47 2.45 2.55 4.99 10.77 11.26 11.23 11.68 7.53 8.11 6.33
Total Assets 4.94 4.94 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.44

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0.00 -0.03 -0.01 -0.06 0.00 -0.50 3.88 0.92 2.82 3.53 0.75 0.33
0.00 0.00 0.00 0.00 0.00 -0.19 -4.23 -3.41 -2.40 -3.15 -1.53 -0.94
0.00 0.03 0.01 0.00 0.10 0.56 1.14 3.10 -0.23 0.40 -0.91 -0.04
Net Cash Flow 0.00 0.00 0.00 -0.06 0.09 -0.14 0.79 0.61 0.20 0.78 -1.69 -0.65

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 60.48 35.01 57.58 23.01 13.61 14.69
Inventory Days 203.34 278.66 88.17 107.27 154.80 286.55
Days Payable 609.39 645.07 311.84 269.40 299.82 309.82
Cash Conversion Cycle -345.57 -331.40 -166.09 -139.12 -131.41 -8.57
Working Capital Days -59.86 -71.84 -56.18 -48.26 -36.02 -0.47
ROCE % -0.62% 0.82% 0.81% 0.20% 0.19% 0.66% 1.56% 8.40% 14.34% 6.13% 3.94%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.83%
69.20% 69.20% 69.20% 69.20% 69.20% 69.19% 69.19% 69.19% 69.20% 69.19% 69.19% 69.16%
No. of Shareholders 1,1881,3441,5261,5511,5901,01,6502,0351,9971,9781,9732,0022,099

Documents